FLCN and cancer: The TGF-beta signaling network, which is often activated in human cancer [66], [67], [68], is also downregulated in FLCN-deficient cells, and mTORC1 signaling can be either up or downregulated in FLCN-deficient cells depending on the cell type and context [21], [25], [49], [55], [56].